Table Filtering
Other Information
Release Statistics Download
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources October 9, 2024
Displaying entries 68101 - 68125 of 71927 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID ▲ Gene Symbol FlyGlycoDB Evidence Code Names References
DOID:1390 hypobetalipoproteinemia SGD:S000000641 Saccharomyces cerevisiae S288C 850412 RRT12
  • MGI:6194238
DOID:13810 familial hypercholesterolemia SGD:S000000641 Saccharomyces cerevisiae S288C 850412 RRT12
  • MGI:6194238
DOID:1909 melanoma SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:326 ischemia SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:305 carcinoma SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:299 adenocarcinoma SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:0110934 nemaline myopathy 7 SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:1062 Fanconi syndrome SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • MGI:6194238
DOID:0070262 congenital disorder of glycosylation type IIj SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:9256 colorectal cancer SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:0070214 familial hyperinsulinemic hypoglycemia 7 SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:1064 cystinosis SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • MGI:6194238
  • PMID:15885099
  • PMID:25860149
DOID:219 colon cancer SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:9993 hypoglycemia SGD:S000000671 Saccharomyces cerevisiae S288C 850438 ERS1
  • PMID:25860149
DOID:1100 ovarian disease SGD:S000000673 Saccharomyces cerevisiae S288C 850440 PAT1
  • MGI:6194238
DOID:1470 major depressive disorder SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:1967 leiomyosarcoma SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:0080985 syndromic X-linked intellectual disorder Lujan-Fryns-type SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:591 phobic disorder SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:14711 FG syndrome SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:9970 obesity SGD:S000000677 Saccharomyces cerevisiae S288C 850442 SRB8
  • MGI:6194238
DOID:0050700 cardiomyopathy SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:655 inherited metabolic disorder SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:1852 intrahepatic cholestasis SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:7148 rheumatoid arthritis SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024